|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0015230,
umls-concept:C0030705,
umls-concept:C0033607,
umls-concept:C0034656,
umls-concept:C0035648,
umls-concept:C0205251,
umls-concept:C0282519,
umls-concept:C0439378,
umls-concept:C0441889,
umls-concept:C1332714,
umls-concept:C1511726,
umls-concept:C1524063,
umls-concept:C2603343,
umls-concept:C2745955
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-1-20
|
|
pubmed:abstractText |
Most of the studies evaluating rash in HIV-positive patients have focused on nonnucleoside reverse transcriptase inhibitors (NNRTI), particularly nevirapine, and little is known about the occurrence of rash and the risk factors for its development in patients receiving regimens not based on NNRTI.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
pubmed-author:AmiciRR,
pubmed-author:AndreottiMM,
pubmed-author:BucciardiniRR,
pubmed-author:FloridiaMM,
pubmed-author:FragolaVV,
pubmed-author:GalluzzoC MCM,
pubmed-author:GianniniGG,
pubmed-author:PirilloM FMF,
pubmed-author:RicciardulliDD,
pubmed-author:TominoCC,
pubmed-author:VelleWW,
pubmed-author:WudlFF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-10
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14731162-Adult,
pubmed-meshheading:14731162-Aged,
pubmed-meshheading:14731162-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:14731162-Drug Eruptions,
pubmed-meshheading:14731162-Exanthema,
pubmed-meshheading:14731162-Female,
pubmed-meshheading:14731162-Follow-Up Studies,
pubmed-meshheading:14731162-HIV Infections,
pubmed-meshheading:14731162-HIV Protease Inhibitors,
pubmed-meshheading:14731162-HIV-1,
pubmed-meshheading:14731162-Humans,
pubmed-meshheading:14731162-Indinavir,
pubmed-meshheading:14731162-Male,
pubmed-meshheading:14731162-Middle Aged,
pubmed-meshheading:14731162-Risk Factors,
pubmed-meshheading:14731162-Ritonavir,
pubmed-meshheading:14731162-Sex Factors,
pubmed-meshheading:14731162-Viral Load
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
|
|
pubmed:affiliation |
Istituto Superiore di Sanità, Rome, Italy. floridia@iss.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
